C213
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C213, covering 2022-05-02 to 2022-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches [Phase 2, Phase 3]